Search by Drug Name or NDC
NDC 25021-0318-02 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is ADENOSINE.
Product Information
| NDC | 25021-0318 |
|---|---|
| Product ID | 25021-318_8a87ae13-88ca-49ae-bfd3-1ffb71cf9cbe |
| Associated GPIs | |
| GCN Sequence Number | 013630 |
| GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 35350 |
| HICL Sequence Number | 003734 |
| HICL Sequence Number Description | ADENOSINE |
| Brand/Generic | Generic |
| Proprietary Name | Adenosine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Adenosine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | ADENOSINE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206778 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0318-02 (25021031802)
| NDC Package Code | 25021-318-02 |
|---|---|
| Billing NDC | 25021031802 |
| Package | 10 VIAL in 1 CARTON (25021-318-02) / 2 mL in 1 VIAL |
| Marketing Start Date | 2023-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |